T cell-targeted biologics such as abatacept also known as CTLA-4 Ig was proven to be efficient in inflammatory diseases such as psoriasis [11] and rheumatoid arthritis (RA) [12]. The gene discussed is CTLA4; the disease is rheumatoid arthritis.